newsThe current position:Home>news

Jiangsu Zhongbang Pharma Passed Esomeprazole Sodium WC Audit By Jiangsu Province Authority 



The certification audit group from Jiangsu Food and Drug Administration has audited Jiangsu Zhongbang Pharma from July 3th to July 5th.

During the two-and-half-day audit, the certification audit group conducted a thorough spot inspection on the factory for Esomeprazole Sodium in strict accordance with EU regulations, which includes Quality Management, Organization and Personnel, Plant and Facilities, Equipment, Validation and Confirmation, File Management, Quality Control, Quality Assurance and other aspects. As a result, the authority made a comprehensive assessment that Jiangsu Zhongbang Pharmas Esomeprazole Sodium complies with the EU requirements.

This event marks a new stage of the companys quality management level and product quality, laying a solid foundation for the companys healthy and sustainable development.On behalf of all staff, the general manager Mr. Xu expressed his sincere thanks to the certification audit group, and said that the company will continue to enhance the level of GMP management and strive to achieve the goal of entering standard drug market.


(Reported by Xiaodan Cong)


On a:Telmisartan- CEP/COS from EDQM     Next: Esomeprazole Magnesium- CEP/COS from EDQM
Website traffic statistics:49676                   © Copyright2012. 江苏中邦制药有限公司. All Rights Reserved